Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination

Biochemistry

Volumn 50, Issue 18, 2011, Pages 3749-3763

  Ahmed, M Rafiuddin ^a   Zhan, Xuanzhi ^a   Song, Xiufeng ^a   Kook, Seunghyi ^a   Gurevich, Vsevolod V ^a   Gurevich, Eugenia V ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRESTINS; BRAIN TISSUE; CELL SIGNALING; CO-IMMUNOPRECIPITATIONS; CONFORMATIONAL EQUILIBRIUM; NOVEL FUNCTIONS; PARKIN BINDS; PARKINSONS DISEASE; PURIFIED PROTEIN; RECEPTOR ACTIVATION; UBIQUITIN LIGASES; UBIQUITINATION;

AMINO ACIDS; PROTEINS; TISSUE;

PARKS;

PARKIN; PROTEIN MDM2; RETINA S ANTIGEN;

ARTICLE; CONFORMATION; GENE MUTATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; UBIQUITINATION;

ANIMALS; ARRESTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; LYSINE; MICE; PARKINSON DISEASE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MDM2; RABBITS; SPECTROMETRY, FLUORESCENCE; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 79955588728     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi200175q     Document Type: Article

References (109)

1. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392, 544-545
2. Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denefle, P., Wood, N. W., Agid, Y., Brice, A., and French Parkinsons Disease Genetics Study Group, and European Consortium on Genetic Susceptibility in Parkinsons Disease (2000) Association between Early-Onset Parkinsons Disease and Mutations in the Parkin Gene N. Engl. J. Med. 342, 1560-1567 (Pubitemid 30340501)
3. Khan, N. L., Scherfler, C., Graham, E., Bhatia, K. P., Quinn, N., Lees, A. J., Brooks, D. J., Wood, N. W., and Piccini, P. (2005) Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation Neurology 64, 134-136 (Pubitemid 40082951)
4. Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn-Hardy, K., Petrucelli, L., Hussey, J., Singleton, A., Tanner, C., Hardy, J., and Langston, W. (2001) Lewy bodies and parkinsonism in families with parkin mutations Ann. Neurol. 50, 293-300 (Pubitemid 32848731)
5. Pramstaller, P. P., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Gonzales-McNeal, M., Hilker, R., Kramer, P. L., and Klein, C. (2005) Lewy body Parkinsons disease in a large pedigree with 77 Parkin mutation carriers Ann. Neurol. 58, 411-422 (Pubitemid 41266627)
6. Kyratzi, E., Pavlaki, M., Kontostavlaki, D., Rideout, H. J., and Stefanis, L. (2007) Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells J. Neurochem. 102, 1292-1303 (Pubitemid 47174231)
7. Sang, T. K., Chang, H. Y., Lawless, G. M., Ratnaparkhi, A., Mee, L., Ackerson, L. C., Maidment, N. T., Krantz, D. E., and Jackson, G. R. (2007) A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine J. Neurosci. 27, 981-992 (Pubitemid 46203305)
8. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., and Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nat. Genet. 25, 302-305 (Pubitemid 30437317)
9. Savitt, J. M., Dawson, V. L., and Dawson, T. M. (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine J. Clin. Invest 116, 1744-1754 (Pubitemid 44033293)
10. Moore, D. J., West, A. B., Dawson, V. L., and Dawson, T. M. (2005) Molecular pathophysiology of Parkinsons disease Annu. Rev. Neurosci. 28, 57-87
11. Gupta, A., Dawson, V. L., and Dawson, T. M. (2008) What causes cell death in Parkinsons disease? Ann. Neurol. 64, S3-15
12. Fallon, L., Belanger, C. M., Corera, A. T., Kontogiannea, M., Regan-Klapisz, E., Moreau, F., Voortman, J., Haber, M., Rouleau, G., Thorarinsdottir, T., Brice, A., van Bergen En Henegouwen, P. M., and Fon, E. A. (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling Nat. Cell Biol. 8, 834-842 (Pubitemid 44151586)
13. Henn, I. H., Bouman, L., Schlehe, J. S., Schlierf, A., Schramm, J. E., Wegener, E., Nakaso, K., Culmsee, C., Berninger, B., Krappmann, D., Tatzelt, J., and Winklhofer, K. F. (2007) Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling J. Neurosci. 27, 1868-1878
14. Avraham, E., Rott, R., Liani, E., Szargel, R., and Engelender, S. (2007) Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation J. Biol. Chem. 282, 12842-12850 (Pubitemid 47100582)
15. Kalia, S. K., Lee, S., Smith, P. D., Liu, L., Crocker, S. J., Thorarinsdottir, T. E., Glover, J. R., Fon, E. A., Park, D. S., and Lozano, A. M. (2004) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration Neuron 44, 931-945 (Pubitemid 39643090)
16. Ko, H. S., Lee, Y., Shin, J. H., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletnikova, O., Troncoso, J. C., Dawson, V. L., and Dawson, T. M. (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkins ubiquitination and protective function Proc. Natl. Acad. Sci. U.S.A. 107, 16691-16696
17. Sato, S., Chiba, T., Sakata, E., Kato, K., Mizuno, Y., Hattori, N., and Tanaka, K. (2006) 14-3-3eta is a novel regulator of parkin ubiquitin ligase EMBO J. 25, 211-221 (Pubitemid 43077309)
18. LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., and Selkoe, D. J. (2005) Dopamine covalently modifies and functionally inactivates parkin Nat. Med. 11, 1214-1221 (Pubitemid 43093669)
19. Winklhofer, K. F., Henn, I. H., Kay-Jackson, P. C., Heller, U., and Tatzelt, J. (2003) Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones J. Biol. Chem. 278, 47199-47208 (Pubitemid 37452306)
20. Yao, D., Gu, Z., Nakamura, T., Shi, Z. Q., Ma, Y., Gaston, B., Palmer, L. A., Rockenstein, E. M., Zhang, Z., Masliah, E., Uehara, T., and Lipton, S. A. (2004) Nitrosative stress linked to sporadic Parkinsons disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity Proc. Natl. Acad. Sci. U. S. A. 101, 10810-10814 (Pubitemid 38955824)
21. Chung, K. K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J. C., Marsh, L., Dawson, V. L., and Dawson, T. M. (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkins protective function Science 304, 1328-1331 (Pubitemid 38697430)
22. Wong, E. S., Tan, J. M., Wang, C., Zhang, Z., Tay, S. P., Zaiden, N., Ko, H. S., Dawson, V. L., Dawson, T. M., and Lim, K. L. (2007) Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations J. Biol. Chem. 282, 12310-12318 (Pubitemid 47100679)
23. Wang, C., Tan, J. M., Ho, M. W., Zaiden, N., Wong, S. H., Chew, C. L., Eng, P. W., Lim, T. M., Dawson, T. M., and Lim, K. L. (2005) Alterations in the solubility and intracellular localization of parkin by several familial Parkinsons disease-linked point mutations J Neurochem. 93, 422-431 (Pubitemid 40547499)
24. Carman, C. V. and Benovic, J. L. (1998) G-protein-coupled receptors: turn-ons and turn-offs Curr. Opin. Neurobiol. 8, 335-344 (Pubitemid 28288568)
25. Gurevich, V. V. and Gurevich, E. V. (2004) The molecular acrobatics of arrestin activation Trends Pharmacol. Sci. 25, 59-112
26. DeWire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) Beta-arrestins and cell signaling Annu. Rev. Physiol. 69, 483-510
27. Gurevich, V. V. and Gurevich, E. V. (2003) The new face of active receptor bound arrestin attracts new partners Structure 11, 1037-1042 (Pubitemid 37103064)
28. Ahn, S., Shenoy, S. K., Wei, H., and Lefkowitz, R. J. (2004) Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor J. Biol. Chem. 279, 35518-35525 (Pubitemid 39100552)
29. Hanson, S. M., Cleghorn, W. M., Francis, D. J., Vishnivetskiy, S. A., Raman, D., Song, X., Nair, K. S., Slepak, V. Z., Klug, C. S., and Gurevich, V. V. (2007) Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity J. Mol. Biol. 368, 375-387 (Pubitemid 46483495)
30. Wang, P., Gao, H., Ni, Y., Wang, B., Wu, Y., Ji, L., Qin, L., Ma, L., and Pei, G. (2003) beta -Arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2 J. Biol. Chem. 278, 6363-6370 (Pubitemid 36800895)
31. Luan, B., Zhang, Z., Wu, Y., Kang, J., and Pei, G. (2005) Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation EMBO J. 24, 4237-4246 (Pubitemid 41828899)
32. Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., and Pei, G. (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways Mol. Cell 14, 303-317 (Pubitemid 38591402)
33. Witherow, D. S., Garrison, T. R., Miller, W. E., and Lefkowitz, R. J. (2004) beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha Proc. Natl. Acad. Sci. U.S.A. 101, 8603-8607 (Pubitemid 38745817)
34. Revankar, C. M., Vines, C. M., Cimino, D. F., and Prossnitz, E. R. (2004) Arrestins block G protein-coupled receptor-mediated apoptosis J. Biol. Chem. 279, 24578-24584 (Pubitemid 38725324)
35. Gurevich, E. V., Benovic, J. L., and Gurevich, V. V. (2002) Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development Neuroscience 109, 421-436 (Pubitemid 34121995)
36. Gurevich, E. V., Benovic, J. L., and Gurevich, V. V. (2004) Arrestin2 expression selectively increases during neural differentiation J. Neurochem. 91, 1404-1416 (Pubitemid 39658567)
37. Ahmed, M. R., Bychkov, E., Gurevich, V. V., Benovic, J. L., and Gurevich, E. V. (2008) Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment J. Neurochem. 104, 1622-1636 (Pubitemid 351316768)
38. Bezard, E., Gross, C. E., Qin, L., Gurevich, V. V., Benovic, J. L., and Gurevich, E. V. (2005) L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain Neurobiol. Dis. 18, 323-335 (Pubitemid 40431116)
39. Hurlé, M. A. (2001) Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity J. Neurochem. 77, 486-492 (Pubitemid 32298743)
40. Bhandari, D., Trejo, J., Benovic, J. L., and Marchese, A. (2007) Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4 J. Biol. Chem. 282, 36971-36979
41. Shenoy, S. K., Xiao, K., Venkataramanan, V., Snyder, P. M., Freedman, N. J., and Weissman, A. M. (2008) NEDD4 mediates agonist-dependent ubiquitination, lysosomal targeting and degradation of the beta 2 adrenergic receptor J. Biol. Chem. 283, 22166-22176
42. Nabhan, J. F., Pan, H., and Lu, Q. (2010) Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor EMBO Rep. 11, 605-611
43. Orsini, M. J. and Benovic, J. L. (1998) Characterization of dominant negative arrestins that inhibit beta2-adrenergic receptor internalization by distinct mechanisms J. Biol. Chem. 273, 34616-34622
44. Mundell, S. J., Loudon, R. P., and Benovic, J. L. (1999) Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels Biochemistry 38, 8723-8732
45. Pan, L., Gurevich, E. V., and Gurevich, V. V. (2003) The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor J. Biol. Chem. 278, 11623-11632 (Pubitemid 36792724)
46. Song, X., Raman, D., Gurevich, E. V., Vishnivetskiy, S. A., and Gurevich, V. V. (2006) Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm J. Biol. Chem. 281, 21491-21499 (Pubitemid 44115487)
47. Moore, D. J., West, A. B., Dikeman, D. A., Dawson, V. L., and Dawson, T. M. (2008) Parkin mediates the degradation-independent ubiquitination of Hsp70 J. Neurochem. 105, 1806-1819 (Pubitemid 351678490)
48. Henn, I. H., Gostner, J. M., Lackner, P., Tatzelt, J., and Winklhofer, K. F. (2005) Pathogenic mutations inactivate parkin by distinct mechanisms J. Neurochem. 92, 114-122 (Pubitemid 40193514)
49. Matsuda, N., Kitami, T., Suzuki, T., Mizuno, Y., Hattori, N., and Tanaka, K. (2006) Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro J. Biol. Chem. 281, 3204-3209 (Pubitemid 43845931)
50. Tohgo, A., Choy, E. W., Gesty-Palmer, D., Pierce, K. L., Laporte, S., Oakley, R. H., Caron, M. G., Lefkowitz, R. J., and Luttrell, L. M. (2003) The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation J. Biol. Chem. 278, 6258-6267 (Pubitemid 36800882)
51. Gurevich, V. V. and Benovic, J. L. (2000) Arrestin: mutagenesis, expression, purification, and functional characterization Methods Enzymol. 315, 422-437
52. Wu, N., Hanson, S. M., Francis, D. J., Vishnivetskiy, S. A., Thibonnier, M., Klug, C. S., Shoham, M., and Gurevich, V. V. (2006) Arrestin binding to calmodulin: a direct interaction between two ubiquitous signaling proteins J. Mol. Biol. 364, 955-963 (Pubitemid 44765044)
53. Vishnivetskiy, S. A., Gimenez, L. E., Francis, D. J., Hanson, S. M., Hubbell, W. L., Klug, C. S., and Gurevich, V. V. (2011) Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. J. Biol. Chem. 286, in press.
54. Sommer, M. E., Smith, W. C., and Farrens, D. L. (2006) Dynamics of arrestin-rhodopsin interactions: acidic phospholipids enable binding of arrestin to purified rhodopsin in detergent J. Biol. Chem. 281, 9407-9417 (Pubitemid 43864657)
55. Baudier, J., Glasser, N., and Duportail, G. (1986) Bimane- and acrylodan-labeled S100 proteins. Role of cysteines-85 alpha and -84 beta in the conformation and calcium binding properties of S100 alpha alpha and S100b (beta beta) proteins Biochemistry 25, 6934-6941 (Pubitemid 17201601)
56. Lakowicz, J. R. (2006) Principles of Fluorescence Spectroscopy, 3rd ed., Springer: New York.
57. Johnson, R. (1996) Elementary Statistics, 7th ed., Wadsworth Publishing Co., Belmont, CA.
58. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., and Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nat. Genet. 25, 302-305 (Pubitemid 30437317)
59. Shenoy, S. K., McDonald, P. H., Kohout, T. A., and Lefkowitz, R. J. (2001) Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin Science 294, 1307-1313 (Pubitemid 33063090)
60. Song, X., Gurevich, E. V., and Gurevich, V. V. (2007) Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites J. Neurochem. 103, 1053-1062 (Pubitemid 47568740)
61. Hanson, S. M., Francis, D. J., Vishnivetskiy, S. A., Klug, C. S., and Gurevich, V. V. (2006) Visual arrestin binding to microtubules involves a distinct conformational change J. Biol. Chem. 281, 9765-9772 (Pubitemid 43864695)
62. Strissel, K. J., Sokolov, M., Trieu, L. H., and Arshavsky, V. Y. (2006) Arrestin translocation is induced at a critical threshold of visual signaling and is superstoichiometric to bleached rhodopsin J. Neurosci. 26, 1146-1153 (Pubitemid 43237047)
63. Hanson, S. M., Gurevich, E. V., Vishnivetskiy, S. A., Ahmed, M. R., Song, X., and Gurevich, V. V. (2007) Each rhodopsin molecule binds its own arrestin Proc. Nat. Acad. Sci. U. S. A. 104, 3125-3128 (Pubitemid 46364124)
64. Song, X., Vishnivetskiy, S. A., Seo, J., Chen, J., Gurevich, E. V., and Gurevich, V. V. (2011) Arrestin1 expression in rods: balancing functional performance and photoreceptor health Neuroscience 174, 37-49
65. Nikonov, S. S., Brown, B. M., Davis, J. A., Zuniga, F. I., Bragin, A., Pugh, E. N., and Craft, C. M. (2008) Mouse cones require an arrestin for normal inactivation of phototransduction Neuron 59, 462-474
66. Xiao, K., McClatchy, D. B., Shukla, A. K., Zhao, Y., Chen, M., Shenoy, S. K., Yates, J. R., and Lefkowitz, R. J. (2007) Functional specialization of beta-arrestin interactions revealed by proteomic analysis Proc. Natl. Acad. Sci. U. S. A. 104, 12011-12016 (Pubitemid 47185621)
67. Gurevich, V. V., Pals-Rylaarsdam, R., Benovic, J. L., Hosey, M. M., and Onorato, J. J. (1997) Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity J. Biol. Chem. 272, 28849-28852 (Pubitemid 27498164)
68. Hanson, S. M., Francis, D. J., Vishnivetskiy, S. A., Kolobova, E. A., Hubbell, W. L., Klug, C. S., and Gurevich, V. V. (2006) Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin Proc. Natl. Acad. Sci. U. S. A. 103, 4900-4905
69. Zhang, Y., Gao, J., Chung, K. K., Huang, H., Dawson, V. L., and Dawson, T. M. (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 Proc. Natl. Acad. Sci. U. S. A. 97, 13354-13359
70. Hanson, S. M., Dawson, E. S., Francis, D. J., Van Eps, N., Klug, C. S., Hubbell, W. L., Meiler, J., and Gurevich, V. V. (2008) A model for the solution structure of the rod arrestin tetramer Structure 16, 924-934 (Pubitemid 351778375)
71. Hanson, S. M., Van Eps, N., Francis, D. J., Altenbach, C., Vishnivetskiy, S. A., Klug, C. S., Hubbell, W. L., and Gurevich, V. V. (2007) Structure and function of the visual arrestin oligomer EMBO J. 26, 1726-1736 (Pubitemid 46480940)
72. Vishnivetskiy, S. A., Francis, D. J., Van Eps, N., Kim, M., Hanson, S. M., Klug, C. S., Hubbell, W. L., and Gurevich, V. V. (2010) The role of arrestin alpha-helix I in receptor binding J. Mol. Biol. 395, 42-54
73. Han, M., Gurevich, V. V., Vishnivetskiy, S. A., Sigler, P. B., and Schubert, C. (2001) Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation Structure 9, 869-880 (Pubitemid 32913504)
74. Hirsch, J. A., Schubert, C., Gurevich, V. V., and Sigler, P. B. (1999) The 2.8 Å crystal structure of visual arrestin: a model for arrestins regulation Cell 97, 257-269
75. Sutton, R. B., Vishnivetskiy, S. A., Robert, J., Hanson, S. M., Raman, D., Knox, B. E., Kono, M., Navarro, J., and Gurevich, V. V. (2005) Crystal structure of cone arrestin at 2.3 Å: evolution of receptor specificity J. Mol. Biol. 354, 1069-1080 (Pubitemid 41698916)
76. Milano, S. K., Pace, H. C., Kim, Y. M., Brenner, C., and Benovic, J. L. (2002) Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis Biochemistry 41, 3321-3328 (Pubitemid 34214030)
77. Zhan, X., Gimenez, L. E., Gurevich, V. V., and Spiller, B. W. (2011) Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual arrestins J. Mol. Biol. 406, 467-478
78. Gurevich, V. V., Dion, S. B., Onorato, J. J., Ptasienski, J., Kim, C. M., Sterne-Marr, R., Hosey, M. M., and Benovic, J. L. (1995) Arrestin interaction with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, b2-adrenergic, and m2 muscarinic cholinergic receptors J. Biol. Chem. 270, 720-731
79. Gurevich, V. V. and Benovic, J. L. (1993) Visual arrestin interaction with rhodopsin: Sequential multisite binding ensures strict selectivity towards light-activated phosphorylated rhodopsin J. Biol. Chem. 268, 11628-11638 (Pubitemid 23168111)
80. Gurevich, V. V. and Benovic, J. L. (1995) Visual arrestin binding to rhodopsin: diverse functional roles of positively charged residues within the phosphorylation-recignition region of arrestin J. Biol. Chem. 270, 6010-6016
81. Song, X., Coffa, S., Fu, H., and Gurevich, V. V. (2009) How does arrestin assemble MAP kinases into a signaling complex? J. Biol. Chem. 284, 685-695
82. Vishnivetskiy, S. A., Hirsch, J. A., Velez, M.-G., Gurevich, Y. V., and Gurevich, V. V. (2002) Transition of arrestin in the active receptor-binding state requires an extended interdomain hinge J. Biol. Chem. 277, 43961-43968
83. Gurevich, V. V. (1998) The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms J. Biol. Chem. 273, 15501-15506 (Pubitemid 28298159)
84. Celver, J., Vishnivetskiy, S. A., Chavkin, C., and Gurevich, V. V. (2002) Conservation of the phosphate-sensitive elements in the arrestin family of proteins J. Biol. Chem. 277, 9043-9048 (Pubitemid 34952978)
85. Carter, J. M., Gurevich, V. V., Prossnitz, E. R., and Engen, J. R. (2005) Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry J. Mol. Biol. 351, 865-878 (Pubitemid 41111902)
86. Song, X., Vishnivetskiy, S. A., Gross, O. P., Emelianoff, K., Mendez, A., Chen, J., Gurevich, E. V., Burns, M. E., and Gurevich, V. V. (2009) Enhanced arrestin facilitates recovery and protects rod photoreceptors deficient in rhodopsin phosphorylation Curr. Biol. 19, 700-705
87. Hanson, S. M. and Gurevich, V. V. (2006) The differential engagement of arrestin surface charges by the various functional forms of the receptor J. Biol. Chem. 281, 3458-3462 (Pubitemid 43845961)
88. Vishnivetskiy, S. A., Hosey, M. M., Benovic, J. L., and Gurevich, V. V. (2004) Mapping the arrestin-receptor interface: structural elements responsible for receptor specificity of arrestin proteins J. Biol. Chem. 279, 1262-1268 (Pubitemid 38082650)
89. Pulvermuller, A., Schroder, K., Fischer, T., and Hofmann, K. P. (2000) Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin J. Biol. Chem. 275, 37679-37685 (Pubitemid 32004881)
90. Ohguro, H., Palczewski, K., Walsh, K. A., and Johnson, R. S. (1994) Topographic study of arrestin using differential chemical modifications and hydrogen/deuterium exchange Protein Sci. 2428-2434
91. Nair, K. S., Hanson, S. M., Mendez, A., Gurevich, E. V., Kennedy, M. J., Shestopalov, V. I., Vishnivetskiy, S. A., Chen, J., Hurley, J. B., Gurevich, V. V., and Slepak, V. Z. (2005) Light-dependent redistribution of arrestin in vertebrate rods is an energy-independent process governed by protein-protein interactions, Neuron 46, 555-567. (Pubitemid 40797381)
92. Gurevich, V. V. and Gurevich, E. V. (2010) Custom-designed proteins as novel therapeutic tools? The case of arrestins Exp. Rev. Mol. Med. 12, e13
93. Shenoy, S. K. and Lefkowitz, R. J. (2005) Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes J. Biol. Chem. 280, 15315-15324 (Pubitemid 40562888)
94. Gurevich, V. V., Gurevich, E. V., and Cleghorn, W. M. (2008) Arrestins as multi-functional signaling adaptors Handbook Exp. Pharmacol. 186, 15-37
95. Vishnivetskiy, S. A., Schubert, C., Climaco, G. C., Gurevich, Y. V., Velez, M.-G., and Gurevich, V. V. (2000) An additional phosphate-binding element in arrestin molecule: implications for the mechanism of arrestin activation J. Biol. Chem. 275, 41049-41057 (Pubitemid 32054932)
96. West, A. B. and Maidment, N. T. (2004) Genetics of parkin-linked disease Hum. Genet. 114, 327-336 (Pubitemid 38324945)
97. Hampe, C., Ardila-Osorio, H., Fournier, M., Brice, A., and Corti, O. (2006) Biochemical analysis of Parkinsons disease-causing variants of PArkin, an E3 ubiquitin-protein ligase with monoubiquitination capacity Hum. Mol. Genet. 15, 2059-2075 (Pubitemid 43923396)
98. Sriram, S. R., Li, X., Ko, H. S., Chung, K. K., Wong, E., Lim, K. L., Dawson, V. L., and Dawson, T. M. (2005) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin Hum. Mol. Genet. 14, 2571-2586 (Pubitemid 41236069)
99. Lesage, S. and Brice, A. (2009) Parkinsons disease: from monogenic forms to genetic susceptibility factors Hum. Mol. Genet. 18, R48-59
100. Ko, H. S., von Coelln, R., Sriram, S. R., Kim, S. W., Chung, K. K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E. L., Song, H., Park, B. J., Kim, M. J., Kim, S., Dawson, V. L., and Dawson, T. M. (2005) Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death J. Neurosci. 25, 7968-7978 (Pubitemid 41254399)
101. Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity Neuron 37, 735-749 (Pubitemid 36288547)
102. Fallon, L., Moreau, F., Croft, B. G., Labib, N., Gu, W. J., and Fon, E. A. (2002) Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain J. Biol. Chem. 277, 486-491 (Pubitemid 34952083)
103. Yamamoto, A., Friedlein, A., Imai, Y., Takahashi, R., Kahle, P. J., and Haass, C. (2005) Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity J. Biol. Chem. 280, 3390-3399 (Pubitemid 40223802)
104. Gurevich, V. V. and Gurevich, E. V. (2006) The structural basis of arrestin-mediated regulation of G protein-coupled receptors Pharmacol. Ther. 110, 465-502
105. Goodman, O. B., Jr., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., and Benovic, J. L. (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor Nature 383, 447-450 (Pubitemid 26330835)
106. McDonald, P. H., Chow, C. W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F. T., Davis, R. J., and Lefkowitz, R. J. (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 Science 290, 1574-1577
107. Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., and Lefkowitz, R. J. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds Proc. Natl. Acad. Sci. U. S. A. 98, 2449-2454 (Pubitemid 32209502)
108. Shiba, K., Arai, T., Sato, S., Kubo, S., Ohba, Y., Mizuno, Y., and Hattori, N. (2009) Parkin stabilizes PINK1 through direct interaction Biochem. Biophys. Res. Commun. 383, 331-335
109. Shenoy, S. K., Modi, A. S., Shukla, A. K., Xiao, K., Berthouze, M., Ahn, S., Wilkinson, K. D., Miller, W. E., and Lefkowitz, R. J. (2009) Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2 Proc. Natl. Acad. Sci. U. S. A. 106, 6650-6655